AnodyneWiki

Levallorphan

Levallorphan
Levallorphan
Salts
[]
Levallorphan tartrate
Levallorphan tartrate
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass283.40 g/mol [1]
AppearanceCRYSTALS FROM DILUTE ETHANOL [1]
Melting point181 °C [1]
Solubility633 mg/L [1]
Predicted LogP3.5 [1]
Structural Identifiers
[]
Molecular formulaC19H25NO
IUPAC name(1R,9R,10R)-17-prop-2-enyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol
SMILESC=CCN1CC[C@]23CCCC[C@H]2[C@H]1CC4=C3C=C(C=C4)O
InChIInChI=1S/C19H25NO/c1-2-10-20-11-9-19-8-4-3-5-16(19)18(20)12-14-6-7-15(21)13-17(14)19/h2,6-7,13,16,18,21H,1,3-5,8-12H2/t16-,18+,19+/m0/s1
InChIKeyOZYUPQUCAUTOBP-QXAKKESOSA-N
CAS number152-02-3
UNII353613BU4U
PubChem CID5359371
Pharmacokinetics[]
Routes of administrationOral

Levallorphan (also known as Naloxiphan, Levallorphane, 17-Allylmorphinan-3-ol, Levalorfano, Levallorphanum, Levallofano, N-Allyl-3-hydroxymorphinan, L-N-Allyl-3-hydroxymorphinan, (-)-3-Hydroxy-N-allylmorphinan or Levo-3-hydroxy-N-allyl morphinan) is a opioid and opioid antagonist substance of the 2-benzylpiperidine and morphinan class.

Chemistry

Salts []

Levallorphan is typically found in the form of its tartrate salt.

 []

Levallorphan is a single defined stereoisomer.

Levallorphan matches Lipinski's rule of five.

There are currently 3 reagent-interactions on

ReagentColor changeDescription
Marquisno color change
Meckeyellow-brown
Froehdeno color change

Pharmacology

Mechanism of action []

Levallorphan antagonizes opioid effects by competing for the same receptor sites. It binds to the opioid mu receptor and the nicotinic acetylcholine receptor alpha2/alpha3. [1]

Subjective effects []

 []

  • Other: Levallorphan is a Rx-only.

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 5359371, Levallorphan. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5359371
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Levallorphan. UNII: 353613BU4U. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/353613BU4U

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 11:17:12
drugsprook2026-11-20 11:17:08
erowidmissing (no Erowid substance of that name)2026-11-20 11:17:08
gsrsok2026-11-20 11:17:09
hmdbmissing (hmdb.ca refused automated access to HMDB0014647)2026-11-20 11:17:08
keggok2026-11-20 11:17:10
pubchemok2026-11-20 11:17:07
redditmissing (no r/tripreports posts mention it)2026-11-20 11:17:08
sidermissing (not in SIDER)2026-11-20 11:17:08
structureok2026-11-20 11:17:08
wikipediaok2026-11-20 11:17:08